Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Calidi Biotherapeutics reported a net loss of $11.9 million for the nine months ended September 30, 2026, compared to a $16.0 million loss in the prior year period. The company maintained a cash balance of $3.9 million as of September 30, 2026, and completed a 1-for-16 reverse stock split in July 2026 to adjust its capital structure.
EQT Private Equity Company LLC reported total investments at fair value of $997.7 million as of September 30, 2026, representing a significant increase from $602.9 million at the end of 2025. The company maintains a diverse share structure across multiple classes and reported $165.6 million in cash and cash equivalents to support its ongoing private equity acquisition strategy.
Stardust Power Inc. reported total assets of $13.4 million and total liabilities of $15.4 million as of September 30, 2026, resulting in a stockholders' deficit. The company faces substantial doubt regarding its ability to continue as a going concern following its delisting from Nasdaq and transition to the Pink Limited Market.
Guru App Factory Corp reported a decline in revenue from $94,500 in 2025 to $52,000 in 2026, primarily due to the non-recurrence of a large software development order. The company's net loss widened to $59,440, and its independent auditor issued a going concern warning due to a working capital deficit and accumulated deficit of $126,863.
Highview Merger Corp. reported a net income of $5.37 million for the nine months ended September 30, 2026, primarily driven by $6.24 million in interest earned on marketable securities held in the Trust Account. As a shell company, its activities are focused on identifying a target for a business combination, with $239.85 million currently held in trust for potential redemptions.
EQT Infrastructure Company LLC reported total investments at fair value of $886.6 million as of September 30, 2026, a significant increase from zero at the end of 2025 following its initial offering in February 2026. The company maintains a complex share structure with over 44 million shares outstanding across various classes, primarily focused on acquiring and managing portfolio companies through joint ventures.
Twelve Seas Investment Company III is a shell company that completed its IPO on December 15, 2025, raising $172.5 million held in trust. As of September 30, 2026, the company has 17,745,000 Class A and 5,692,500 Class B ordinary shares outstanding and is seeking a business combination within a 24-month window ending December 15, 2027.
Trade Desk Insider Samantha Jacobson Sells $96.6K of Stock
Samantha Jacobson sold 6,042 shares of Trade Desk, Inc. at $15.99 a share, worth $96.6K in total on Nov 11, 2026. Shares held after the trade: 7,057 (-46.1%).
SoundHound AI, Inc. appointed Tyler Moore as Chief Accounting Officer and principal accounting officer, effective November 9, 2026. Mr. Moore's compensation package includes an annual base salary of $345,000, a 40% target bonus, 100,000 restricted stock units vesting over four years, and 50,000 performance stock units. He succeeds John Collins, who will continue to serve as the company's Chief Financial Officer.
NeOnc Technologies announced that CEO Amir Heshmatpour purchased 80,000 shares of common stock in the open market, bringing his total 2026 personal investment to 271,000 shares. Additionally, the company received a Type B End-of-Phase meeting from the FDA scheduled for January 2027 to discuss an accelerated approval pathway for its brain cancer candidate, NEO100.
Beyond Air reported record quarterly revenue of $2.3 million for the period ended September 30, 2026, representing 28% year-over-year growth. The company reaffirmed its revenue guidance of $8 million for CY2026 and $16-$18 million for CY2027 while awaiting FDA approval for its second-generation LungFit PH system.
Term
Q2 2027
“Building on the commercial momentum we are generating with our first-generation LungFit PH system, we believe our second-generation system has the potential to substantially expand our market opportunity and accelerate growth, pending FDA approval.”
Robert Goodman, Chief Executive Officer of Beyond Air
“We remain encouraged by our active and productive discussions with the FDA and the progress we are making toward completing the remaining steps in the review process for the second-generation LungFit PH system.”
Robert Goodman, Chief Executive Officer of Beyond Air
Co-Diagnostics held a court-ordered special meeting of shareholders on November 13, 2026, where shareholders elected five directors and approved an amendment to the 2025 Equity Incentive Plan. The amendment increases the number of shares authorized for issuance under the plan by 2,000,000 shares, bringing the total maximum to 2,223,333 shares. Shareholders also approved a non-binding advisory resolution regarding executive compensation.
Q/C Technologies received a deficiency notice from Nasdaq on November 6, 2026, because its common stock failed to maintain a minimum bid price of $1.00 per share for 30 consecutive business days. The company has 180 calendar days, or until May 5, 2027, to regain compliance with the minimum bid price requirement. If compliance is not regained, the company may be eligible for an additional 180-day period or face delisting.
NextBoat $823K Debt Financing with Hadley Harbor Group LLC
NextBoat Inc.'s subsidiary, Off The Hook Yacht Sales NC, LLC, entered into a seven-year triple-net lease for 22 boat slips at Cape Fear Marina with Hadley Harbor Group LLC. The company provided a corporate guaranty for the lease obligations, which total approximately $0.82 million in base rent over the term. The transaction is a related-party deal involving the company's Chairman and a Director.
Delta Air Lines EVP - Global Sales & Distrib Steven M. Sear Sells $1.58M of Stock
Steven M. Sear, EVP - Global Sales & Distrib, sold 17,768 shares of Delta Air Lines, Inc. at $88.95 a share, worth $1.58M in total on Nov 12, 2026. Shares held after the trade: 86,636 (-17.0%).
Spruce Power Holding Corp reported 19,294,133 shares of common stock outstanding as of November 9, 2026. The company's cash and cash equivalents decreased from $54.8 million at the end of 2025 to $40.1 million as of September 30, 2026, while management highlighted risks related to debt refinancing and solar industry demand.
BRC Group Holdings, Inc. announced it is eliminating the role of Chief Accounting Officer effective November 16, 2026. As a result, Howard Weitzman will step down from the position but will remain with the company as Head of Corporate Tax, transitioning out of his status as an executive officer.
Evofem Biosciences reported Q3 2026 financial results, achieving $0.7 million in operating income despite a slight decline in net sales to $4.6 million. The company highlighted the shipment of its 500,000th box of PHEXX and the addition of a fifth study site for an NIH-funded Phase 4 trial of SOLOSEC.
Term
Q3 2026
“While third quarter net sales reflect the cumulative impact of operating without dedicated growth capital for brand promotion and physician outreach since late 2022, we are proud of the discipline, efficiency and tenacity demonstrated across the organization. Through rigorous expense management, we generated $0.7 million of operating income during the quarter while continuing to support patients and healthcare providers who rely on our innovative sexual health products.”
byNordic Acquisition Corp deposited $8,850.20 into its trust account to extend the deadline for completing its initial business combination by one month. The extension moves the termination date from November 12, 2026, to December 12, 2026, and represents the fourth of twelve possible monthly extensions.
BioScience Health Innovations, Inc. reported a net loss of $564,885 for the nine months ended September 30, 2026, a significant decline from the $875,720 net income in the prior year period. Despite the loss, the company successfully raised over $2 million through common stock sales, ending the period with a strengthened cash position of $1,691,858.
KKR Private Equity Conglomerate LLC reported a net increase in net assets resulting from operations of $975.5 million for the nine months ended September 30, 2026, compared to $762.1 million in the prior year period. Total assets grew to $13.6 billion, driven by a significant increase in investments at fair value and cash holdings.
Evofem Biosciences reported a significant decline in total assets from $20.3 million at year-end 2025 to $7.3 million as of September 30, 2026, driven largely by a decrease in trade accounts receivable and intangible assets. The company faces substantial liquidity challenges with $84.8 million in current liabilities and has received notices of default from Future Pak, LLC regarding its debt obligations.
Senior Credit Investments, LLC reported a net increase in member’s capital resulting from operations of $18.4 million for the nine months ended September 30, 2026, up from $12.0 million in the prior year period. Total investment income grew significantly to $40.4 million, driven by interest income from its non-controlled/non-affiliated investment portfolio, while net asset value per unit decreased slightly to $1,767.94 from $1,787.98 at year-end 2025.
Jefferies Credit Partners BDC Inc. reported a net increase in net assets resulting from operations of $52.0 million for the nine months ended September 30, 2026, compared to $30.5 million for the same period in 2025. Total net assets grew to $964.9 million from $677.0 million at year-end 2025, driven by significant capital share issuances and investment income growth.
The 21Shares Solana Staking ETF reported net assets of $9,786,070 as of September 30, 2026, a significant increase from $5,735,019 at the end of 2025. The Trust generated $102,143 in staking rewards for the nine months ended September 30, 2026, and transitioned its pricing benchmark to the FTSE Solana Index in August 2026.
Mirum Pharmaceuticals Director Laura Brege Sells $1.33M of Stock
Laura Brege, Director, sold 14,167 shares of Mirum Pharmaceuticals, Inc. at $94.05 to $94.74 a share (average $94.21) in 2 transactions, worth $1.33M in total on Nov 11, 2026. Shares held after the trade: 15,703 (-17.2%).
Vital Farms 10% Owner Matthew Ohayer Sells $222K of Stock
Matthew Ohayer, 10% Owner, sold 23,250 shares of Vital Farms, Inc. at $9.56 a share, worth $222K in total on Nov 11, 2026. Shares held after the trade: 6,238,720 (-0.4%).
Blue Line Holdings, Inc. remains a pre-revenue industrial company with a net loss of $12,459 for the quarter ended September 30, 2026. The company reported a working capital deficit of $90,521 and expressed substantial doubt regarding its ability to continue as a going concern without additional financing.
INNOVATE Corp. filed a prospectus supplement to establish a new $50 million at-the-market (ATM) equity offering program through Jefferies LLC. This program replaces a previous registration statement that expired in October 2026 and increases the potential offering amount from $31 million to $50 million. The filing also includes pro forma financial data reflecting the company's recent divestitures of its Broadcasting and DBM Global business units.
For the quarter ended September 30, 2026, INVE Technologies reported a net income of $0.6 million, a significant improvement from a $3.5 million loss in the prior year, primarily driven by a $6.1 million gain on an asset sale. However, total revenue decreased to $3.1 million from $5.0 million year-over-year, and the company recorded a nine-month net loss of $7.5 million.